Try our Advanced Search for more refined results
Life Sciences - December, 2012
154 articles
- Judge Unseals FCA Suit Against Millennium, Schering
- NECC Buckles Under Meningitis Suits, Files For Ch. 11
- Push For More Animal Antibiotics Data Could Expose Secrets
- Former SAC Manager Won't 'Flip' In Insider Trading Case
- Vaccine Buyers Get Sanofi's Antitrust Claim Scrapped
- Gilead Ditches Double-Patenting Claim In Tamiflu Suit
- RI Judge Finds Aredia Suit Against Novartis Time-Barred
- Pfizer To Pay $1M Over Ore.'s Claims It Flouted Ads Pact
- Allergan Rivals' Eyelash Treatments Are Drugs, Court Rules
- The Year The AIA's Post-Grant Processes Took Hold
- EU AstraZeneca Ruling — A Letdown For Life Sciences Cos.
- DOJ Drops $83M FCA Medicare Case Against Fresenius
- Ex-Banker Nabbed Over Role In $2B Olympus Accounting Scam
- Indiana Won't Sign Onto $48M Healthpoint FCA Deal
- GSK Tells 3rd Circ. Thalidomide Row Belongs In Fed. Court
- Judge Questions Validity Of Cephalon's Epilepsy Drug Patent
- Half Of Venable's Requested Fees Granted In FTC Acai Suit
- Eli Lilly Strikes $29.4M Settlement Over FCPA Claims
- Ky. AG Can't Escape Merck Outside Counsel Case
- Wilson Sonsini Expands China Practice With Beijing Office
- FDA Slaps New Warning On Vertex's Hep C Drug After Deaths
- Beware Discovery In 3rd-Party Litigation Funding
- GSK To Pay $150M To Settle Direct Purchasers' Flonase Suit
- States Push FDA To Hone Compounding Oversight Plan
- Sanofi Pays $109M For Fine Dining Kickbacks, Illicit Samples
- Bard Defends Fed. Circ. Ruling In Graft IP Case To High Court
- DC Circ. Shelves Contraception Suit To Await ACA Rule
- Bard Survives Bid To Remand Vascular Filter Defect Suit
- Battle Over Labeling Genetically Modified Food Continues
- Ex-S&N Reps Barred From Client Contact In $56M Secrets Row
- Pa. Hospital Hits Cardinal, Owens & Minor With Antitrust Suit
- FDA Signals Fresh Scrutiny Of Opioid Painkillers
- Plan To Share Clinical Data Could Stifle EU Drug Innovation
- IRS Lends Device Makers Leeway On Industry-Loathed Tax
- Seller Of Fake Diabetic Test Strips Gets 5 Years Probation
- FDA Says 5 Eye Care Providers' Lasik Ads Mask Risks
- Ex-Takeda Contractor Loses Bid To Revive 2 FCA Suits
- Amgen Cops To Aranesp Misbranding, Will Pay $762M
- Stryker, Others Face FCA Suit Over Pain-Pump Marketing
- Drug Co. Lied About $245M Buyout Offer, SEC Claims
- Emerging Trends In Nucleic Acids And Human Genome Work
- SG Urges Justices To Reject Hatch-Waxman Safe Harbor Case
- FDA Issues New Guidelines On Clinical Trial Enrichment
- Novartis Gets Expert Testimony Blocked In Aredia-Zometa MDL
- Bayer One-A-Day False Ad Class Action Axed
- Lab Testing Co. Genelex Hit With DNA Patent Suit
- Drug Supplier Possibly Lied About FDA Docs, Judge Says
- 'Don't Ask, Don't Waive' Standstills And The Auction Problem
- More Flexibility On Gift-Giving For Pharma Manufacturers
- Aalto's Faulty-Vial Suit Belongs In Fed. Court, Wheaton Says
- Drug Co. Misrepresented Products' FDA Status, SEC Says
- Orthofix To Pay $42M To End DOJ Medicare Fraud Case
- Genzyme, Cobrek End Kidney Drug Patent Fight
- Fed. Circ. Upholds AstraZeneca's Crestor Patent
- Mylan's Latest Focalin ANDA Brings Novartis IP Suit
- Diversion Scheme Faked Origin Of $440M In Drugs, US Says
- Caronia And The 'New' 1st Amendment Safe Harbor
- FCPA Guide's Lessons For Life Sciences Companies
- Pfizer Loses Bid To Undo Retaliation Verdict In 2nd Circ.
- US Targets Vein Treatment's Marketing In FCA Suit
- Merck Must Hand Over Vioxx Gov't Docs, NJ Judge Says
- Vertical Pharma Suit Claims Deloitte Derailed Acquisition
- Lathrop & Gage Boosts IP Practice With Boutique
- FDA Directs Drugmakers To Make Drugs Less Confusing
- Astellas Seeks To Block Fresenius Generic Adenoscan
- J&J Balks At Ark.'s $181M Risperdal Legal Fee Request
- Why The FCC Matters To Medical Devices
- EU Unitary Patent System Has Major Cos. Wary
- Endo Targets Actavis Over Generic Versions Of Opana
- Plaintiffs Drop Accutane Suits Booted From Philly Tort System
- Pfizer Chantix Trials Show More Heart Troubles In Users: FDA
- Boston Scientific Says 1st-To-File Rule Bars Kickback Suit
- Pfizer Reaches $42.9M Accord With States In Marketing Row
- Roche Says NJ Judge Biased In Accutane Mass Tort Litigation
- Novartis' Exelon Patent Is Invalid, UK Appeals Court Says
- Gilead Shells Out $510M For YM BioSciences
- Allergan Can't Dodge Trade Secrets Suit, NJ Judge Rules
- Pfizer Pays $55M For Off-Label Promotion Of Wyeth's Protonix
- How Justices May Be Leaning In Amgen Argument
- Noteworthy Lessons From FDA Suspension Of Sunland
- Lilly Sues USPTO For Extra 1.5 Years On Cancer Patent
- Philips Can't Escape Consumer Class Action Over AirFloss
- GSK Asks Supreme Court To Weigh Double Avandia Damages
- SEC Can't Prove Stock Buyback Scheme, GSK Unit Says
- Stryker, Wright Medical Settle Suit Over Knee Implant Website
- Meningitis Plaintiff Seeks To Bar NECC From Shredding Docs
- US Must Give Medicare Info In $726M Heart Implant FCA Suit
- New FDA Guidance: What Review Boards Should Do
- Patent Validity Issue Underpins High Court Pay-For-Delay Case
- Zimmer Loses Bid To Pare Suit From Knee Implant MDL
- Sullivan & Cromwell Guides Amgen on $415M DeCODE Buy
- Generics Cos. Ask Fed. Circ. To Nix Pfizer's Lyrica Patent
- Senators Want $29B Medical Device Excise Tax Put On Hold
- 2nd Circ. Backs Another Eli Lilly Win In Zyprexa MDL
- Weston Presidio Sells Evenflo Breastfeeding Unit To PE Firm
- Del. Court Asks France To Compel Bristol-Myers VP's Testimony
- Mass. Pharmacies Now Under Greater Scrutiny
- Mylan Claims Ranbaxy Sitting On Hypertension Drug Exclusivity
- Calif.'s Prop 37 And Food Policy: What Happens Next?
- Medline Workers Ask 9th Circ. For Class Cert. In Wage Case
- Pfizer, Genentech Target Roxane Over Generic Cancer Drug
- Supreme Court To Hear FTC Pay-For-Delay Antitrust Suit
- Lawmakers Want Compounding Group To Cough Up Docs
- Kilpatrick Adds Life Sciences Patent Ace In Atlanta
- No Immediate Appeal For Ex-ArthroCare Execs In SEC Suit
- RI Health Workers Sue To Block State's Flu Shot Mandate
- Zimmer Loses Bid For $1.4M Award In Stryker Poaching Suit
- Pharma Groups Take On Calif. County's Drug Disposal Rule
- Carlyle's Claris Sells $194M Stake, Forms Injections JV
- EU AstraZeneca Ruling Raises Bar For IP Monopoly Abuse
- Free Speech Protects Unapproved Drug Marketing, 9th Circ. Told
- Meningitis Plaintiffs Likely To Get Peek At NECC Facility
- K-Dur Doesn't Apply To Authorized Generic Deals, Judge Says
- 39 Nexium Bone Density Suits Consolidated By MDL Panel
- House Dem Pushes For Health IT Funding, New FDA Office
- House Dems Float Compounding Oversight Bill
- McKesson Pays $9.84M To Settle Ky. Drug Price Inflation Suit
- Drug Labs Alkem, Sidmak Sued Over Acne Drug ANDA
- Cardinal, Owens & Minor Hit With $200M Antitrust Suit
- Recent Life Sciences Patent Cases: Sound The Alarm?
- Healthpoint, DFB To Pay $48M To End FCA Drug Suit
- Life Sciences MVP: Weil's Liz Weiswasser
- Landmark 2nd Circ. Decision Means Victory For Pharm Cos.
- K-V Pharma, Hologic Eye $60M Deal To End Makena Feud
- Clinics Can't Dodge Varian Cancer Device Patent Claims
- IRS Finalizes $29B Medical Device Excise Tax
- OPM Details Multistate Health Plans On ACA Exchanges
- Life Sciences MVP: Morgan Lewis' Randall Sunberg
- FDA Wrongfully Withheld Animal Antibiotic Data, Suit Says
- Walgreen Demands Toss Of Suit Over Joint Products Labeling
- J&J Exits Ex-Sales Reps' Suit Over Noncompete Deal
- Bayer Blasts Expert In Vitamin False Ad Class Action
- 2nd Circ. Ruling Presents Risks For Drug Cos. In Litigation
- Align Technology Execs Netted $52M Via Fraud, Suit Says
- Importers Didn't Breach Kaneka's Enzyme Patent, ITC Finds
- Pfizer Tells 8th Circ. Generic Drug Injury Claims Fail
- Travelers, St. Paul Fight Coverage of W.Va. 'Pill Mill' Suit
- Life Sciences MVP: O'Melveny's Paul Scrivano
- Dorsey & Whitney Draws Medical Device Pro To Calif. IP Team
- Kirkland & Ellis Aids Linden's $314M Dental Co. Buyout
- Ranbaxy Hit With Class Action Over Generic Lipitor Recall
- A Troubling Trend For Personalized Medicine Patents
- Kirkland Guides Baxter's $4B Buy Of Dialysis Co. Gambro
- 1st Circ. Set To Weigh In On FCA First-To-File Rule
- P&G, Canfield Sue Over Skin Imaging Patents
- Myriad Patent Case Tees Up 2 Key Issues For High Court
- Heart Docs Hit Forest Labs With Class Action Over Junk Faxes
- Life Sciences MVP: Kirkland & Ellis' Jay Lefkowitz
- 2nd Circ. Shields Drugmakers From Gov't Marketing Probes
- Nonprofit Fights Sanofi Subpoena In Antitrust Suit
- Plaintiffs Lose Doc Request In Pfizer Epilepsy Drug MDL
- GCs Name Most Arrogant Law Firms
- Endo Claims Opana Generic Versions Ripe For Misuse, Abuse
- Supreme Court Won't Examine Fen-Phen Atty's Fraud Conviction